Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 6, 2026 | $1.10 | −26.2% | $789.61M | +5.9% | $1.10 |
| Q1 FY26ended Mar 31, 2026 | May 14, 2026 | $0.90 | +66.7% | $759.85M | +27.0% | $0.92 |
| Q4 FY25ended Dec 31, 2025 | — | $1.03 | +442.1% | $826.42M | +25.7% | — |
| Q3 FY25ended Sep 30, 2025 | — | $0.88 | +131.6% | $769.05M | +22.9% | — |
| Q2 FY25ended Jun 30, 2025 | — | $1.49 | +547.8% | $745.34M | +18.4% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.54 | — | $598.12M | −1.4% | — |
| Q4 FY24ended Dec 31, 2024 | — | $0.19 | +72.7% | $657.29M | +6.6% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.38 | +3700.0% | $625.71M | +63.1% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Globus Medical shares, not any token. As of Aug 6, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $0.23 | — | $629.69M | — | — |
| Q1 FY24ended Mar 31, 2024 | — | −$0.05 | — | $606.67M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.11 | — | $616.53M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.01 | — | $383.64M | — | — |